Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Gedeon Richter Gains on Chinese Sales Expansion: Budapest Mover

Gedeon Richter Nyrt., Hungary’s biggest drugmaker, advanced for the first time in four days after announcing a joint venture to expand sales in China.

Richter shares rose 1.1 percent to 35,125 forint by the end of trading in Budapest. The benchmark BUX stock fell 0.2 percent.

Richter signed agreements with the owners of its marketing partner Rxmidas Pharmaceuticals Co. Ltd. to create a joint venture, according to a statement to the Budapest Stock Exchange today. The deal, which will give Richter seven regional offices and more than 200 staff in China, will help expand the company’s 2013 revenue by 7.3 billion forint ($33 million), according to KBC Groep NV’s broker unit.

“We welcome the expansion and diversification plan as China is one of the fastest growing pharmaceutical markets in the world,” Gergely Palffy, a Budapest-based analyst at KBC Securities, wrote in a research report.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.